M&A Ophthalmology Deals Continue Into 2023 with Small And Mid-Size Transactions
The first quarter of 2023 delivered ten reported ophthalmology practice acquisitions, which aligns with seasonal acquisition trends (Q1 of 2022 reported eleven deals).
OPHTHALMOLOGY: A Great Time for Sellers to Do a Deal
The ophthalmology sector continues to be a robust market entering Q2 2023. There are more than 25 core private equity platforms within ophthalmology, plus smaller regional PE-backed groups. Read more here.
Real Estate Valuations Explained
How do practice valuations compare to those of real estate? What does it take to maximize real estate value? Watch our video to learn more.
EBITDA Valuations Explained
Do you know what two factors drive the most value in your practice sale? How are practices even valued by private equity investors? Hear it directly from one of our seasoned investment bankers.
Valuation Differences Between Practice and Real Estate
How do private equity firms value practices and ASC’s? How do real estate buyers value your healthcare facility? It's important to understand how the two connect.
The Winning Team
A solid team is the key to a successful transaction.
What We Love About Ophthalmology
Ophthalmology M&A has been very active. All of FOCUS' recent transactions have been with private-equity backed buyers.
Plastic Surgery & Aesthetics – A New PE Darling We Should Have Noticed Sooner
The plastic surgery and aesthetics space is showing signs of increasing private equity activity.
FOCUS Investment Banking Represents The Retina Eye Center in its Sale to Retina Consultants of America
Washington, DC, (August 17, 2022) – FOCUS Investment Banking (“FOCUS”), a ...
The Retina Eye Center has been acquired by Retina Consultants of America
Washington, DC, (August 17, 2022) – FOCUS Investment Banking (“FOCUS”), a ...